Effects of rs7903146 Variation in the Tcf7l2 Gene in the Lipid Metabolism of Three Different Populations

Perez-Martinez, Pablo; Perez-Caballero, Ana I.; Garcia-Rios, Antonio; Yubero-Serrano, Elena M.; Camargo, Antonio; Gomez-Luna, Maria J.; Marin, Carmen; Gomez-Luna, Purificacion; Dembinska-Kiec, Aldona; Rodriguez-Cantalejo, Fernando; Tinahones, Francisco J.; Roche, Helen M.; Perez-Jimenez, Francisco; Lopez-Miranda, Jose; Delgado-Lista, Javier; Clarke, Robert
August 2012
PLoS ONE;Aug2012, Vol. 7 Issue 8, Special section p1
Academic Journal
Background: TCF7L2 rs7903146 is an important genetic factor predicting type 2 diabetes (T2DM) which has also been linked to higher cardiovascular risk. To date, there is little information about the additional impact of this single nucleotide polymorphism (SNP) beyond glucose metabolism. Methodology/Principal Findings: We studied whether rs7903146 influenced postprandial lipid metabolism in three different populations (healthy young men, metabolic syndrome (MetS) patients and elderly persons). Eighty-eight healthy males were submitted to a single saturated fatty acid-rich test meal. Additionally, 110 middle-aged MetS patients and 20 healthy elderly persons (≥65 years) were submitted to three different dietary models followed by test meals. Minor allele homozygotes for rs7903146 showed a worse postprandial lipemia profile in young males, as seen by a lower HDL-cholesterol and Apo A1 concentration during the postprandial lipemia and a trend towards higher triglycerides (TG), than the other genotypes. In healthy elderly persons, carriers of the minor allele showed higher total cholesterol, LDL-cholesterol, Apo B and TG in the fasting state, and a higher postprandial area under the curve for total cholesterol, Apo B, small- triglyceride rich lipoprotein (TRL) cholesterol and small-(TRL) triglycerides. These results were accompanied by differential changes in adipokines. We did not observe any influence of rs7903146 on the postprandium of MetS patients. Conclusions/Significance: Healthy young males and elderly persons who are carriers of the mutant allele for rs7903146 have an impaired postprandial lipid metabolism that may be mediated by an alteration in adipokine regulation, and may be related to the higher cardiovascular risk observed in these persons. Trial Registration: ClinicalTrials.gov NCT00429195


Related Articles

  • Lipid profile in type 2 diabetic and hypertensive population in Western Algeria. Gormat, N. Brixi; Benmansour, F.; Hammas, A. // Annals of Biological Research;2011, Vol. 2 Issue 4, p447 

    Dyslipidemia in diabetics are as high blood pressure to take very seriously, given the significant increase in cardiovascular risks they pose to patients. Anomalies of lipoprotein metabolism are of major importance because of the risks atherogenic increased in diabetic patients. [4, 11] In this...

  • Impact of type 2 diabetes and the metabolic syndrome on myocardial structure and microvasculature of men with coronary artery disease.  // Cardiovascular Diabetology;2011, Vol. 10 Issue 1, p80 

    The article informs on a research that analyzes the effect of type two 2 diabetes and metabolic syndrome on myocardial structure and microvasculature of patients with coronary artery disease. It is mentioned that type two diabetes and metabolic syndrome are often the causative factors for...

  • Cardiovascular risk in type 1 diabetes mellitus. Ines Ben Hadj Slama Slim // Indian Journal of Endocrinology & Metabolism;2013 Supplement, Vol. 17 Issue S1, pS7 

    Commonly cardiovascular risk (CVR) is linked to type 2 diabetes mellitus as this type is known to be part of the metabolic syndrome, which includes other cardiovascular factors such as hypertension, dyslipidemia. Inversely, CVR of type 1 diabetes mellitus (T1 DM) is currently being debated apart...

  • Nutrigenetics and Metabolic Disease: Current Status and Implications for Personalised Nutrition. Phillips, Catherine M. // Nutrients;Jan2013, Vol. 5 Issue 1, p32 

    Obesity, particularly central adiposity, is the primary causal factor in the development of insulin resistance, the hallmark of the metabolic syndrome (MetS), a common condition characterized by dyslipidaemia and hypertension, which is associated with increased risk of cardiovascular disease...

  • Genetic and Environmental Determinants of Dimethylarginines and Association With Cardiovascular Disease in Patients With Type 2 Diabetes. Anderssohn, Maike; McLachlan, Stela; Lüneburg, Nicole; Robertson, Christine; Schwedhelm, Edzard; Williamson, Rachel M.; Strachan, Mark W. J.; Ajjan, Ramzi; Grant, Peter J.; Böger, Rainer H.; Price, Jackie F. // Diabetes Care;Mar2013, Vol. 37 Issue 3, p846 

    OBJECTIVE To investigate determinants of asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA), including single nucleotide polymorphisms (SNPs), in the DDAH1, DDAH2, and AGXT2 genes and their associations with prevalent and incident cardiovascular disease (CVD) in older...

  • Nutrapharmacology of Tocotrienols for Metabolic Syndrome. Weng-Yew, Wong; Brown, Lindsay // Current Pharmaceutical Design;7/11/2011, Vol. 17 Issue 21, p2206 

    Metabolic syndrome is defined as a set of health risk factors that are associated with an increased chance of cardiovascular diseases and type 2 diabetes. These include abdominal obesity, hyperglycemia, impaired glucose tolerance, dyslipidemia, and hypertension. Interventions in metabolic...

  • Utility of Serum Inflammatory Chemokines as Markers of Metabolic Syndrome and Type II Diabetes Mellitus. Saleh, Doaa N.; Eman M. Saleh; Shaheen, Karim Y.; Shalaby, Kamal A. // Australian Journal of Basic & Applied Sciences;Jul2012, Vol. 6 Issue 7, p144 

    Background: Inflammation has repeatedly been demonstrated to be associated with themetabolic syndrome (MS) and type II diabetes mellitus (type II DM), but the relative importance ofdifferent aspects of inflammatory process is largely unexplored. Subjects: Circulating adipokine(chemerin) and...

  • PREVALENCE OF CARDIOVASCULAR RISK FACTORS IN RELATION TO METABOLIC SYNDROME IN THE ROMA POPULATION COMPARED WITH THE NON-ROMA POPULATION IN THE EASTERN PART OF SLOVAKIA. Fedačko, Ján; Pella, Daniel; Jarčuška, Peter; Siegfried, Leonard; Janičko, Martin; Veselíny, Eduard; Pella, Jozef; Sabol, František; Jarčuška, Pavol; Mareková, Mária; Gecková, Andrea Madarasová; Pažinka, Peter; Jankajová, Monika; Kmec, Ján; Babčák, Marián; Kalanin, Peter; Dražilová, Sylvia; Babinská, Ingrid; Čečetková, Beáta // Central European Journal of Public Health;Mar2014 Supplement, pS69 

    Background: Obesity-induced metabolic syndrome is a multiple risk factor for cardiovascular (CV) risk factors and type 2 diabetes, and ethnic minorities seem to have unfavourable medical risk factors in general more frequently than majority populations. Objective: The aim of this study was to...

  • Improvement of Insulin Resistance and Reduction of Cardiovascular Risk Among Obese Patients with Type 2 Diabetes with the Duodenojejunal Bypass Liner. Hourneaux de Moura, Eduardo Guimarães; Bonotto Orso, Ivan Roberto; Martins, Bruno da Costa; Lopes, Guilherme Sauniti; de Oliveira, Suzana Lopes; Galvão-Neto, Manoel dos Passos; Mancini, Marcio Correa; Santo, Marco Aurélio; Sakai, Paulo; Ramos, Almino Cardoso; Garrido-Júnior, Arthur Belarmino; Halpern, Alfredo; Cecconello, Ivan // Obesity Surgery;Jul2011, Vol. 21 Issue 7, p941 

    Background: This study aims to evaluate the effectiveness of the duodenojejunal bypass liner (DJBL) in the improvement of insulin resistance and reduction of cardiovascular risk among morbidly obese patients with type 2 diabetes mellitus, using the triglyceride/high-density lipoprotein (HDL)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics